Sponsor GmbH
Sponsor GmbH
Explore linked clinical trials.6 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| JS111 in Patients With Advanced NSCLC Harboring EGFR Mutations | non-small cell lung carcinoma | Active, not recruiting | Phase 1 / Phase 2 | 2026-07-07 | NCT06940401 | |
| Phase I Study of WJ47156 Monotherarpy and in Combination With Other Therapy in Advanced Solid Tumors | Advanced Malignant Solid Tumors | Active, not recruiting | Phase 1 | 2026-07-07 | NCT06571422 | |
| The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of JS207 in Patients With Advanced Malignant Tumor | Advanced Malignant Tumor | Active, not recruiting | Phase 1 | 2026-07-02 | NCT06022250 | |
| A Study Explore WJB001 Capsules in Patients With Advanced Solid Tumors | Advanced Solid Tumors | Recruiting | Phase 1 / Phase 2 | 2026-04-01 | NCT05773820 | |
| Pharmacy-led Transitions of Care Intervention to Improve Medication Adherence | Arrhythmias, Cardiac, Arterial Occlusive Diseases, Chronic Disease, Chronic Kidney Diseases, Disease Attributes, Dyslipidemias, Embolism, Embolism and Thrombosis, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Hypercholesterolemia, Infarction, Lipid Metabolism Disorders, Male Urogenital Diseases, Necrosis, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, anxiety, anxiety disorder, arteriosclerosis disorder, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, chronic renal failure syndrome, congestive heart failure, coronary artery disorder, depressive disorder, diabetes mellitus, endocrine system disorder, glucose metabolism disease, heart disorder, heart failure, hyperlipidemia, hypertensive disorder, ischemic disease, kidney disorder, kidney failure, lung disorder, metabolic disease, myocardial infarction, myocardial ischemia, nervous system disorder, psychiatric disorder, pulmonary embolism, respiratory system disorder, stroke disorder, urinary system disorder, vascular disorder | Recruiting | Not applicable | 2026-01-29 | NCT06374277 | |
| JS001sc or JS001 Plus Chemotherapy is Indicated for Relapsed or Metastatic First-Line Non-Squamous Non Small Cell Lung Cancer（NSCLC） | Recurrent Metastatic Non-Squamous Non Small Cell Lung Cancer | Active, not recruiting | Phase 3 | 2025-08-28 | NCT06505837 |